09.19.25 -- CSL Behring's Robotics Push Is One Of The Biggest We've Seen Yet

Explore four common applications of cryopreservation and the science behind selecting the appropriate materials to build single-use solutions that enable cryogenic storage for cell and gene applications.

As manufacturers develop more advanced therapeutics, particularly cell and gene therapies, it becomes clear why solutions that support reliable cold chains will become central.

Connect your experiments directly with your data analysis tools today to unlock the power of your data for smarter and faster decisions relating to DoE studies – design, execution, and analysis.

Formulation development is a vital part of the drug development process. Each therapeutic behaves differently, and it’s critical to complete buffer optimization work for better clinical success.

Conversion of cellulose to bioethanol has huge potential to positively impact the global energy crisis, helping enable a shift away from fossil fuel dependency.

Properly trained visual inspectors are crucial for identifying defects in parenteral drugs, safeguarding patient safety and product quality.

In cell processing, rigid, single-function equipment can lead to inefficiencies, wasted space, and scheduling conflicts. A versatile approach can help teams do more with less.

Uncover the development work involved for the individual technologies that make up an innovative and scalable, chemical-free, continuous viral vector production platform.

Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. See how the following considerations help companies choose between in-house and outsourced strategies.

Discover how a novel titer quantification method stacks up against ELISA and HPLC in this data-rich comparison of precision, accuracy, and cost.

With these four steps to successful biologic process development, it is possible to mitigate risk, manufacture a high-quality product, and increase the efficiency of your timeline to patients.

Learn about the benefits of microfluidics for nanoparticle production over traditional methods as well as scaling nanoparticle production for clinical or industrial use.

How this comprehensive approach to operational readiness and excellence helped a site implement a new PMO, align with the parent organization's goals, and build a foundation for sustained success.